semaglutide for autoimmune disease GLP-1 and Disease: Evidence & Provider Guidance From Prescription to Predicament: A – semaglutide autoimmune may Improve Metabolic

Patients should contact their GP or diabetes specialist nurse if dizziness occurs frequently, interferes with daily activities, or persists beyond the initial adjustment period

Patients using semaglutide routinely report diminished hunger, prompt fullness during meals, reduced cravings, increased energy for physical pursuits, and improved blood pressure, cholesterol, and blood sugar levels

There have been safety concerns due to some compounded versions containing salt forms of the drug

As these hormones regulate the menstrual cycle, even minor shifts may cause obvious changes

However, these findings remain preliminary, inconsistent across studies, and have not been robustly demonstrated in well-designed human clinical trials